Update on treatment options for Lambert-Eaton myasthenic syndrome: focus on use of amifampridine
about
Synthesis and biological evaluation of a selective N- and p/q-type calcium channel agonist.Paraneoplastic syndromes associated with lung cancerSynaptic Pathophysiology and Treatment of Lambert-Eaton Myasthenic Syndrome.Genetic variation in aryl N-acetyltransferase results in significant differences in the pharmacokinetic and safety profiles of amifampridine (3,4-diaminopyridine) phosphate.Voltage gated calcium channel antibody-related neurological diseasesComplete reversal of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K+ channel blocker and a Ca2+ channel agonist.The association between Lambert-Eaton myasthenic syndrome and small cell lung carcinomaSnakebite management in Iran: Devising a protocolPopulation Pharmacokinetics/Pharmacodynamics of 3,4-Diaminopyridine Free Base in Patients With Lambert-Eaton MyastheniaThe role of laminins in the organization and function of neuromuscular junctions.Lambert-Eaton myasthenic syndrome: mouse passive-transfer model illuminates disease pathology and facilitates testing therapeutic leads.
P2860
Q33752856-68B6E7F4-5DAA-4751-A99B-B9CAEBBD3929Q34023610-86C83C02-805D-4391-9818-F56BC8295908Q34437216-D15F7C12-2470-4546-9FD6-419B54A80BBEQ35049590-4888FE09-C888-4D64-81AD-245DE5449317Q35179343-EFE91E20-1AB4-4E2E-9F50-D1CE9940D360Q35205835-C4A4263D-7D4C-479A-9046-E49DFFD8CC3DQ37054967-A7503D4B-7281-4A42-AB75-AC7C3338235EQ37723218-2F99532D-DF5D-46F5-8EC0-0238968AE37AQ38721390-2632C5E3-9F7E-4365-84C6-8C935F8EC573Q38950913-86DA5259-9DFC-438A-B93D-5D4EE09D5FF9Q50073063-435D9FA0-DFE4-4D0F-9D84-92D5E98C176A
P2860
Update on treatment options for Lambert-Eaton myasthenic syndrome: focus on use of amifampridine
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Update on treatment options fo ...... focus on use of amifampridine
@ast
Update on treatment options fo ...... focus on use of amifampridine
@en
Update on treatment options fo ...... focus on use of amifampridine
@nl
type
label
Update on treatment options fo ...... focus on use of amifampridine
@ast
Update on treatment options fo ...... focus on use of amifampridine
@en
Update on treatment options fo ...... focus on use of amifampridine
@nl
prefLabel
Update on treatment options fo ...... focus on use of amifampridine
@ast
Update on treatment options fo ...... focus on use of amifampridine
@en
Update on treatment options fo ...... focus on use of amifampridine
@nl
P2860
P356
P1476
Update on treatment options fo ...... focus on use of amifampridine
@en
P2093
Martin Stangel
Sabine Lindquist
P2860
P304
P356
10.2147/NDT.S10464
P407
P577
2011-05-30T00:00:00Z